5 Reasons LD May Outperform EVD in aSAH: Is Lumbar Drainage the Superior Strategy?
International Journal of Stroke (IJS), official journal of World Stroke Organization, shared a newly piblished study on X:
”New systematic review and meta analysis compares outcomes of external ventricular drainage and lumbar drainage in aSAH. When directly compared, LD was favored to EVD for early functional independence and survival”
Read the full article here.
In patients with aneurysmal subarachnoid hemorrhage (aSAH), cerebrospinal fluid diversion via lumbar drainage (LD) or external ventricular drainage (EVD) plays a critical role in managing complications.
In the recently published comprehensive meta-analysis ‘‘Outcomes of External Ventricular Drainage, and Lumbar Drainage in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review, and Meta-Analysis” by Basel Musmar, Pascal Jabbour et al. in the IJS, a comparative overview of LD and EVD approaches in aSAH is discussed.
- LD was associated with lower risks of vasospasm, ischemic complications, severe disability, and mortality without an increased risk of rebleeding.
- EVD effectively reduced ischemic events but carried a higher infection risk.
Direct comparisons suggest LD may offer advantages in early functional recovery and survival, though clinical context and patient severity remain key considerations.
Further research is warranted to guide optimal intervention strategies!
All the latest scientific advancements in the field of thrombosis and bleeding featured in Hemostasis Today.
-
Sep 9, 2025, 05:53Noel Hiney Highlights the Value of Blood Donation and Community Support
-
Sep 8, 2025, 22:5650% of DOAC Doses are Inappropriate in Older Adults? On The Role of Appropriate Dosing
-
Sep 8, 2025, 07:48Andreas Zirlik Announces EAS Rare Lipid Disorders Course at 7th Cardio Summit Graz
-
Sep 8, 2025, 07:11Naveen Pemmaraju at SOHO 2025: Presenting Effects of Rusfertide for Polycythemia Vera on Behalf of VERIFY Colleagues
-
Sep 8, 2025, 06:54Indraneel Deshmukh Presenting Posters on Polycytemia Vera and More at SOHO 2025
-
Sep 8, 2025, 14:22GLP-1 Receptor Agonists and Cardiovascular Benefits․ Role of Clinical Features
-
Sep 8, 2025, 14:21Hamza A. Salim: CTA Collateral Impairment Score Enhances Stroke Prognosis Accuracy
-
Sep 8, 2025, 06:19Maria Abbattista: From Combined Hormonal Contraceptives to Cerebral Vein Thrombosis
-
Sep 8, 2025, 06:12David Smadja: Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes
-
Sep 7, 2025, 17:19Tessa Jaspers and Colleagues on Current Evidence Not Supporting Routine Anti-Xa Monitoring in Use of LMWH
-
Sep 8, 2025, 14:24Von Willebrand Factor as a Therapeutic Target․ From Development to Clinical Application
-
Sep 8, 2025, 02:35Reza Shojaei on the Real Worth of Hemoglobin Oxygen Carriers – HBOCs
-
Sep 7, 2025, 14:16Mary Kiige: Biological Hemoglobin Oxygen Carrier as a Lifesaving Oxygen Bridge
-
Sep 7, 2025, 14:13Breakthrough in Blood: Cécile Denis and INSERM Team Develop Nanobody Therapy for Type 1 VWD
-
Sep 2, 2025, 13:53Cost-Effective Strategies to Reduce Anaemia Highlighted in The Lancet Haematology
-
Sep 9, 2025, 04:57World Thrombosis Day 2025: Louise Bannon Invites Donations and Partnerships
-
Sep 8, 2025, 15:10Michael Makris on WHO’s Essential Medicines List Update: A Win for the Global Haemophilia Community
-
Sep 8, 2025, 14:26European Haemophilia Consortium Marks World PT Day: Physiotherapy Empowers People with Bleeding Disorders
-
Sep 8, 2025, 07:03Omar Adwan Explains the Key Difference Between Serum and Plasma
-
Sep 8, 2025, 07:00French Reference Center for Hemophilia Presented at The 22nd Turkish Hemophilia Congress